1-3463209-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014448.4(ARHGEF16):c.125C>T(p.Pro42Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,546,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014448.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF16 | NM_014448.4 | c.125C>T | p.Pro42Leu | missense_variant | 2/15 | ENST00000378378.9 | NP_055263.2 | |
ARHGEF16 | XM_017001049.2 | c.176C>T | p.Pro59Leu | missense_variant | 2/15 | XP_016856538.1 | ||
ARHGEF16 | XM_017001051.2 | c.125C>T | p.Pro42Leu | missense_variant | 2/15 | XP_016856540.1 | ||
ARHGEF16 | XM_047418009.1 | c.176C>T | p.Pro59Leu | missense_variant | 2/8 | XP_047273965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF16 | ENST00000378378.9 | c.125C>T | p.Pro42Leu | missense_variant | 2/15 | 2 | NM_014448.4 | ENSP00000367629 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000132 AC: 2AN: 152022Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 80932
GnomAD4 exome AF: 0.0000108 AC: 15AN: 1393768Hom.: 0 Cov.: 31 AF XY: 0.0000117 AC XY: 8AN XY: 686642
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at